Clinical Trial Update: Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Exploratory Phase 1/2 trial evaluating HRS-4642 in combination with Adebelimab for advanced pancreatic cancer; study status: recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adebelimab (adebelimab)
• HRS-4642

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING